PATENT CLAIM ANALYSIS

Application Number: 15889409
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["549", "398000"]

Abstract:
Synthetic cremastranone and cremastranone analogs are disclosed. Additionally, methods for synthesizing cremastranone and cremastranone analogs are disclosed. Methods of treating ocular neovascularization disorders and treating angiogenesis-mediated disease are also disclosed.

Claim (Index 1):
A method of treating retinoblastoma in a subject in need thereof, the method comprising administering an effective amount of the compound of formula (I) wherein R 1 , R 2 , R 3 , R 4 , and R 5  are independently selected from the group consisting of hydrogen, hydroxyl, alkoxy, substituted alkoxy, alkyl carbonyloxy, substituted alkyl carbonyloxy, alkyl carbonyl, substituted alkyl carbonyl, aryl carbonyloxy, substituted aryl carbonyloxy, halogen, amino, nitro, hydrocarbyl and substituted hydrocarbyl; and X, Y, and Z are independently selected from the group consisting of carbon, nitrogen, and oxygen.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 88.0
- Lexical Diversity: 1.61905
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15523670', '12086792', '13582487', '13946959', '14156314']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6960387414265187
- 35 USC 102 Novelty (BERT): 0.5187858061552906
- Combined Prediction Score: 0.6783134478993958
- Mean Citation Score: 276.669304
- Max Citation Score: 284.84555
- Similarity Product: 193.88265215179624

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test